ULTRA Study for Pacemaker Patients

Inclusion Criteria: * Patients who meet current INSIGNIA® Ultra pacemaker indications * Patients who will be programmed to a pacing mode of DDD, DDDR, VVI, VVIR, or VDD at the time of implant * Patients who sign and date a Patient Informed Consent form at or prior to the implant visit * Patients who remain in the clinical care of the enrolling physician in approved centers Exclusion Criteria: * Patients who will receive a single chamber device with an atrial lead only * Patients who have chronic leads with a ventricular threshold of more than 4.0 V * Patients whose life expectancy is less than 12 months * Patients who are expected to receive a heart transplant during the duration of the study * Patients who have or who are likely to receive a tricuspid valve prosthesis * Patients who are currently enrolled in another investigational study that would directly impact the treatment or outcome of the ULTRA study. * Patients who are younger than 18 years of age * Patients who are pregnant * Patients who are mentally incompetent and cannot sign a Patient Informed Consent form or comply with the study